GCV Symposium 2017
Skip Content

20 March 2017

eGenesis proceeds to $38m series A

Heritage Provider Network is among a consortium of investors that provided $38m in series A capital to genome editing technology developer eGenesis.

Author: Thierry Heles, Reporter

US-based genetics technology developer eGenesis has raised $38m in a series A round backed by healthcare services provider Heritage Provider Network.


Subscribe now

Latest Magazine

Editor’s picks

Most popular

Events

23 May 2017

GCV Symposium 2017 - London

Join 400+ business leaders from the corporate venturing and wider high growth business ecosystem for the two-day 2017 GCV Symposium.

11 April 2017

Canadian Corporate Innovation Summit 2017

April 11 to 13, 2017 at the Fairmont Royal York in Downtown Toronto.

23 April 2017

UniVenture Visions 2017 Symposium – Hong Kong

The Coller Institute of Venture and the AUTM Asia 2017 Conference have announced UniVenture Visions, an exclusive symposium that shall trigger the thinking and discussion necessary to evolve research universities…

More events